Ponatinib | High-Quality Pharmaceutical Reference Standard
Ponatinib is a tyrosine kinase inhibitor used in the treatment of Philadelphia chromosome–positive (Ph+) chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL), including resistant or refractory cases. It works by inhibiting BCR-ABL kinase and other kinases, suppressing malignant cell proliferation. Ponatinib API is produced under GMP standards and is suitable for oral solid dosage formulations, including tablets.
Ponatinib API is manufactured and supplied by Artis Biotech | ASTANDARDS, ensuring high purity, consistent quality, and regulatory-compliant specifications. Our APIs are produced using validated processes and are suitable for research, development, and pharmaceutical manufacturing applications.
Total Products : 6
